BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maioli E, Daveri E, Maellaro E, Ietta F, Cresti L, Valacchi G. Non-conventional rottlerin anticancer properties. Arch Biochem Biophys 2018;645:50-3. [PMID: 29545132 DOI: 10.1016/j.abb.2018.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Zheng N, Wang L, Hou Y, Zhou X, He Y, Wang Z. Rottlerin inhibits cell growth and invasion via down-regulation of EZH2 in prostate cancer. Cell Cycle 2018;17:2460-73. [PMID: 30394832 DOI: 10.1080/15384101.2018.1542897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
2 Qomaladewi NP, Kim MY, Cho JY. Rottlerin Reduces cAMP/CREB-Mediated Melanogenesis via Regulation of Autophagy. Int J Mol Sci 2019;20:E2081. [PMID: 31035588 DOI: 10.3390/ijms20092081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
3 Al-Bari MAA, Ito Y, Ahmed S, Radwan N, Ahmed HS, Eid N. Targeting Autophagy with Natural Products as a Potential Therapeutic Approach for Cancer. Int J Mol Sci 2021;22:9807. [PMID: 34575981 DOI: 10.3390/ijms22189807] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wu D, Pan J, Zhang D. Inhibition of PKC-δ reduce rhabdomyolysis-induced acute kidney injury. J Cell Mol Med 2022. [PMID: 35502493 DOI: 10.1111/jcmm.17331] [Reference Citation Analysis]